Impact of multidrug-resistantPseudomonas aeruginosainfection on patient outcomes
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of multidrug-resistantPseudomonas aeruginosainfection on patient outcomes
Authors
Keywords
-
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 10, Issue 4, Pages 441-451
Publisher
Informa UK Limited
Online
2010-08-18
DOI
10.1586/erp.10.49
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa
- (2010) V. H. Tam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug‐Resistant Bacteria in a Murine Pneumonia Model
- (2010) Zhe Yuan et al. JOURNAL OF INFECTIOUS DISEASES
- Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria
- (2009) P. D. Mauldin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduced expression of virulence factors in multidrug-resistant Pseudomonas aeruginosa strains
- (2009) Aleksander Deptuła et al. ARCHIVES OF MICROBIOLOGY
- Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
- (2009) Anand Kumar et al. CHEST
- Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship
- (2009) Rebecca R. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
- (2009) Joshua D. Hartzell et al. CLINICAL INFECTIOUS DISEASES
- Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is Nephrotoxic
- (2009) Sara E. Cosgrove et al. CLINICAL INFECTIOUS DISEASES
- Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia
- (2009) Vincent H. Tam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Efflux-Mediated Drug Resistance in Bacteria
- (2009) Xian-Zhi Li et al. DRUGS
- Imipenem Resistance in Pseudomonas aeruginosa Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
- (2009) Ebbing Lautenbach et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Combination Antimicrobial Treatment Versus Monotherapy: The Contribution of Meta-analyses
- (2009) Mical Paul et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Clinical characteristics and risk factors of colistin-induced nephrotoxicity
- (2009) Jieun Kim et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Nomenclature of Plasmid-Mediated 16S rRNA Methylases Responsible for Panaminoglycoside Resistance
- (2008) Y. Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Broad‐Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up Front
- (2008) Marin H. Kollef CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Pseudomonas aeruginosa Serious Infections: Mono or Combination Antimicrobial Therapy?
- (2008) Matteo Bassetti et al. CURRENT MEDICINAL CHEMISTRY
- Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms
- (2008) Zhe Yuan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now